IBD risk increases with Enbrel therapy for other autoimmune diseases

Patients receiving Enbrel for inflammatory diseases other than inflammatory bowel disease have an increased risk for a diagnosis of Crohn’s disease or ulcerative colitis, according to study results.
Joshua Korzenik, MD, director of the Crohn’s and Colitis Center at Brigham and Women’s Hospital, and colleagues wrote in Alimentary Pharmacology & Therapeutics that anti-TNF treatments have made a significant impact on the management of autoimmune disease like rheumatoid arthritis and IBD. However, they do not come without risks.
“Paradoxically, these agents might provoke

Source link

Related posts

ACG President announces GI-focused MOC alternative in the works


Predictive values of colorectal cancer alarm symptoms in the general population: a nationwide cohort study


How to treat and prevent bacterial gastroenteritis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy